These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16444179)

  • 1. Growth in disorders of adrenal hyperfunction.
    Magiakou MA
    Pediatr Endocrinol Rev; 2004 Aug; 1 Suppl 3():484-9. PubMed ID: 16444179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth in disorders of adrenal hyperfunction.
    Savage MO; Scommegna S; Carroll PV; Ho JT; Monson JP; Besser GM; Grossman AB
    Horm Res; 2002; 58 Suppl 1():39-43. PubMed ID: 12373013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth patterns and outcomes in congenital adrenal hyperplasia; effect of chronic treatment regimens.
    Rasat R; Espiner EA; Abbott GD
    N Z Med J; 1995 Aug; 108(1005):311-4. PubMed ID: 7644165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth abnormalities associated with adrenal disorders and their management.
    Savage MO; Lebrethon MC; Blair JC; Ho JT; Johnston LB; Lienhardt A; Clark AJ; Chaussain JL
    Horm Res; 2001; 56 Suppl 1():19-23. PubMed ID: 11786680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [11beta-hydroxylase deficiency: improvement of final height with growth hormone and gonadotropin-releasing hormone analog].
    Orío Hernández M; Yebra Yebra J; Bezanilla López C; Gracia Bouthelier R
    An Pediatr (Barc); 2007 Aug; 67(2):153-6. PubMed ID: 17692261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth in children with adrenocortical tumors.
    Hauffa BP; Roll C; Mühlenberg R; Havers W
    Klin Padiatr; 1991; 203(2):83-7. PubMed ID: 2033910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of final height in patients with pituitary growth hormone deficiency who were treated with growth hormone replacement].
    Korpal-Szczyrska M; Dorant B; Kamińska H; Birkholz D; Niedźwiecki M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):31-4. PubMed ID: 16704859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth pattern and final height in 21-hydroxylase deficiency.
    Bajpai A; Pandey RM; Kabra M; Menon PS
    Indian Pediatr; 2007 Oct; 44(10):771-3. PubMed ID: 17998577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of increased height velocity in the first year of life in untreated children with simple virilizing congenital adrenal hyperplasia.
    Claahsen-van der Grinten HL; Noordam K; Borm GF; Otten BJ
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1205-9. PubMed ID: 16464952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercortisolism in childhood: shortcomings of conventional diagnostic criteria.
    Streeten DH; Faas FH; Elders MJ; Dalakos TG; Voorhess M
    Pediatrics; 1975 Nov; 56(5):797-803. PubMed ID: 1196738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth pattern and skeletal maturation following growth hormone therapy in growth hormone deficiency: factors influencing outcome.
    Bajpai A; Kabra M; Gupta AK; Menon PS
    Indian Pediatr; 2006 Jul; 43(7):593-9. PubMed ID: 16891678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome.
    Blum WF; Cao D; Hesse V; Fricke-Otto S; Ross JL; Jones C; Quigley CA; Binder G
    Horm Res; 2009; 71(3):167-72. PubMed ID: 19188742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the effects of therapy on growth and bone mineralization in children with congenital adrenal hyperplasia.
    Gallagher MP; Levine LS; Oberfield SE
    Growth Horm IGF Res; 2005 Jul; 15 Suppl A():S26-30. PubMed ID: 16039891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of cortisol hypersecretion in the pathogenesis of osteoporosis].
    Chiodini I; Scillitani A
    Recenti Prog Med; 2008 Jun; 99(6):309-13. PubMed ID: 18710063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal growth spurt and final height despite low levels of all forms of circulating insulin-like growth factor-I in a patient with acid-labile subunit deficiency.
    Domené HM; Martínez AS; Frystyk J; Bengolea SV; Ropelato MG; Scaglia PA; Chen JW; Heuck C; Wolthers OD; Heinrich JJ; Jasper HG
    Horm Res; 2007; 67(5):243-9. PubMed ID: 17213728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Female pseudohermaphroditism. A propos of 2 cases].
    Zmerli S; Maloum A; Sehairi K
    J Urol Nephrol (Paris); 1972; 78(1):81-4. PubMed ID: 4341111
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of male adrenogenital syndrome (report of 17 cases)].
    Liu GH; Li HZ; Li YQ; Ji ZG; Jin W; Li HJ
    Zhonghua Nan Ke Xue; 2006 Jul; 12(7):633-5. PubMed ID: 16894944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catch-up growth in autosomal dominant isolated growth hormone deficiency (IGHD type II).
    Binder G; Iliev DI; Mullis PE; Ranke MB
    Growth Horm IGF Res; 2007 Jun; 17(3):242-8. PubMed ID: 17360215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Final height in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: the Italian experience.
    Brunelli VL; Russo G; Bertelloni S; Gargantini L; Balducci R; Chiesa L; Livieri C; De Sanctis C; Einaudi S; Virdis R; Saggese G; Chiumello G
    J Pediatr Endocrinol Metab; 2003 Mar; 16 Suppl 2():277-83. PubMed ID: 12729404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.